{"nct_id":"NCT00650793","title":"A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia","status":"COMPLETED","status_verified_date":"2010-04","start_date":"2004-03","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2006-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}